Metaphedrine

Designer drug From Wikipedia, the free encyclopedia

3-Methylmethamphetamine (3-MMA or 3-Me-MA), also known as metaphedrine, is an amphetamine derivative which has been sold as a designer drug, first encountered online in 2020 and reported in Sweden in 2021.[1][2] It is a potent monoamine reuptake inhibitor[3] and is thought to have psychostimulant effects.[2] The drug was not active as a serotonin 5-HT2A receptor agonist.[3]

Other names3-Methyl-N-methylamphetamine; 3-MMA; 3MMA; 3-Me-MA; Metaphedrine
Legal status
Quick facts Clinical data, Other names ...
Metaphedrine
Clinical data
Other names3-Methyl-N-methylamphetamine; 3-MMA; 3MMA; 3-Me-MA; Metaphedrine
Legal status
Legal status
Identifiers
  • N-methyl-1-(3-methylphenyl)propan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC11H17N
Molar mass163.264 g·mol−1
3D model (JSmol)
  • CC1=CC(=CC=C1)CC(C)NC
  • InChI=1S/C11H17N/c1-9-5-4-6-11(7-9)8-10(2)12-3/h4-7,10,12H,8H2,1-3H3
  • Key:CXVNKBVJDKMLOH-UHFFFAOYSA-N
Close

See also

References

Related Articles

Wikiwand AI